Wockhardt — 360° view

Wockhardt, a company in the Pharmaceuticals industry, reported revenue of ₹969 crore and net profit of ₹73 crore for the September 2026 quarter.

Wockhardt (NSE: WOCKPHARMA) closed at ₹2,184.40 on 20 Nov 2026, up 64.8% over the past year. Its market capitalisation is ₹35,499 crore and it trades at 88.8 times earnings.

Share price
₹2,184.40 (20 Nov 2026)
Market cap
₹35,499 Cr (20 Nov 2026)
P/E
88.81 (20 Nov 2026)
Revenue
₹969 Cr (September 2026 quarter)
Net profit
₹73 Cr (September 2026 quarter)
ROCE
7.55% (FY26)
ROE
6.11% (FY26)
Book value
₹317 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹2,422.30 / ₹1,086.70 (20 Nov 2026)
1-year return
64.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: WOCKPHARMA

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams and ointments).

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.